Therma Bright Inc (CVE:THRM) (OTCMKTS:TBRIF) Stock In Focus After Recent Developments

February 17, 2022

At this point in time, Therma Bright Inc (CVE:THRM) (OTCMKTS:TBRIF) is best known for having developed the AcuVid™ COVID-19 Rapid Antigen Saliva Test. However, it is perhaps also important for investors to keep in mind that the company is also involved in the development of other forms of medical devices as well as technologies for the diagnostics space. AcuVid(TM) U.S. Clinical Performance Study Successfully Exceeds U.S. Food & Drug Administration’s…

Read More >>